Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Go back to Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
(NASDAQ: TSHA) Delayed: 5.76 +0.18 (3.23%)
Previous Close $5.58    52 Week High
Open $5.58    52 Week Low
Day High $6.06    P/E N/A 
Day Low $5.55    EPS
Volume 1,383,602